NCT01625845 Anti-INFLammatory to Address Mood and Endothelial Dysfunction (INFLAMED) Status COMPLETED Phase PHASE2
NCT01613820 Ketamine and Scopolamine Infusions for Treatment-resistant Major Depressive Disorder Status WITHDRAWN Phase NA
NCT01608399 Clinical Trial of the Effectiveness of Metacognitive Therapy in the Treatment of Patients With Major Depressive Disorder Status COMPLETED Phase NA
NCT01606384 Evaluation of the Potential Effects of SSR149415 on the Hypothalamic-pituitary-adrenal Axis in Outpatients With Major Depressive Disorder Status COMPLETED Phase PHASE2
NCT01601210 Dose-Ranging Trial of Creatine Augmentation for Adolescent Females With Treatment-Resistant Major Depressive Disorder Status COMPLETED Phase EARLY_PHASE1
NCT01601002 LEPR Polymorphism Weight Gain by Mirtazapine in Late Life Depression Status COMPLETED Phase PHASE4
NCT01598922 Internet Based Cognitive Behavioral Therapy Effects on Depressive Cognitions and Brain Function Status COMPLETED Phase NA
NCT01594866 Lexapro®'s Efficacy After Dose Escalation in Remission Study Status COMPLETED Phase PHASE4
NCT01590862 ON/OFF Stimulation and Reward Motivation in Patients With Deep Brain Stimulators Status COMPLETED Phase NA
NCT01583998 Electronic-Measurement Based Care for Major Depressive Disorder Status WITHDRAWN Phase NA
NCT01582945 Ketamine Infusion for Treatment-resistant Major Depressive Disorder Status COMPLETED Phase NA
NCT01582815 A Study of JNJ-40411813 as Supplementary Treatment to an Antidepressant in Adults With Depression and Anxiety Symptoms Status COMPLETED Phase PHASE2
NCT01582581 Study of Technology-assisted Treatment of Adolescent Depression Status COMPLETED Phase NA
NCT01579942 Potential Use Of Brain Network Activation Analysis to Diagnose Major Depression Status TERMINATED Phase N/A
NCT01573741 Study of Ketamine as an Antidepressant in Major Depressive Disorder Status UNKNOWN Phase PHASE1/PHASE2
NCT01573598 Safety and Efficacy of Vilazodone in Major Depressive Disorder Status COMPLETED Phase PHASE4
NCT01571453 Study of Vortioxetine (Lu AA21004) in Major Depressive Disorder in Asian Countries Status COMPLETED Phase PHASE3